{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:22:08Z","timestamp":1761740528490},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.2950","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T07:17:10Z","timestamp":1420442230000},"page":"75-78","source":"Crossref","is-referenced-by-count":19,"title":["Human T Lymphotropic Virus Type-1-associated Myelopathy Manifesting Shortly after Living-donor Renal Transplantation"],"prefix":"10.2169","volume":"54","author":[{"given":"Yuito","family":"Nagamine","sequence":"first","affiliation":[{"name":"Department of Neurology, Saitama Medical University International Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University International Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University International Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohsuke","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University International Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Tanahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University International Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Poiesz B, Ruscetti F, Gazdar A, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419, 1980.","DOI":"10.1073\/pnas.77.12.7415"},{"key":"2","unstructured":"2. Hlela C, Shepperd S, Khumalo N, et al. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev 11: 205-214, 2009."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Watanabe T. Current status of HTLV-1 infection. Int J Hematol 94: 430-434, 2011.","DOI":"10.1007\/s12185-011-0934-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Igakura T, Stinchcombe J, Goon P, et al. Spread of HTLV-1 between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299: 1713-1716, 2003.","DOI":"10.1126\/science.1080115"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bangham C. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol 84: 3177-3189, 2003.","DOI":"10.1099\/vir.0.19334-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Manns A, Hisada M, La GL. Human T-lymphotropic virus type I chain reaction study infection. Lancet 353: 1951-1958, 1999.","DOI":"10.1016\/S0140-6736(98)09460-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Osame M, Usuku K, Izumo S, et al. HTLV-1-associated myelopathy, a new clinical entity. Lancet 1: 1031-1032, 1986.","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"8","unstructured":"8. Taylor G; HERN. The epidemiology and clinical impact of HTLV infections in Europe. AIDS Rev 1: 195-204, 1999."},{"key":"9","unstructured":"9. Verdonck K, González E, Van Dooren S, et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266-281, 2007."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Casseb J, Oliveira AC. Low risk of tropical spastic paraparesis\/human T lymphotropic virus type 1-associated myelopathy development among persons aged >50 years. Clin Infect Dis 47: 728-729, 2008.","DOI":"10.1086\/590969"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 322: 383-388, 1990.","DOI":"10.1056\/NEJM199002083220607"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kuroda Y, Takashima H, Yukitake M, et al. Development of HTLV-1 associated myelopathy after blood transfusion in a patient with aplastic anemia and a recipient of renal transplant. J Neurol Sci 109: 196-199, 1992.","DOI":"10.1016\/0022-510X(92)90168-K"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakatsuji Y, Sugai F, Watanabe S, et al. HTLV-1-associated myelopathy manifested after renal transplantation. J Neurol Sci 177: 154-156, 2000.","DOI":"10.1016\/S0022-510X(00)00332-4"},{"key":"14","unstructured":"14. Shinntani Y, Hirano A, Inagaki T, et al. A case of HTLV-1 associated myelopathy manifested after cadaveric renal transplantation. Ishoku (Japanese Journal of Transplantation) 37: 85-87, 2002 (in Japanese, Abstract in English)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zarranz J, Gomes J, Rouco I, et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 74: 1080-1084, 2003.","DOI":"10.1136\/jnnp.74.8.1080"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Inose Y, Akiyama S, Mochizuki A, et al. A case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation. Clin Neurol 50: 241-245, 2010.","DOI":"10.5692\/clinicalneurol.50.241"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nakamura N, Tamaru S, Ohshima K. Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc 37: 1779-1782, 2005.","DOI":"10.1016\/j.transproceed.2005.03.132"},{"key":"18","unstructured":"18. Naghibi O, Nazemian F, Naghibi M, et al. Prognosis of HTLV-1 positive renal transplant recipients in Iran. Saudi J Kidney Dis Transpl 22: 670-674, 2011."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I proviral load correlates with progression of motor disability in HAM\/TSP: Analysis of 239 HAM\/TSP patients including 64 patients followed up for 10 years. J Neurovirol 7: 228-234, 2001.","DOI":"10.1080\/13550280152403272"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Caillard S, Dharnidharka V, Agodoa L, et al. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80: 1233, 2005.","DOI":"10.1097\/01.tp.0000179639.98338.39"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kawano N, Shimoda K, Ishikawa F, et al. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 82: 840-843, 2006.","DOI":"10.1097\/01.tp.0000235186.30113.c7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nakagawa N, Nakahara K, Maruyama Y, et al. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neurovirology 2: 345-355, 1996.","DOI":"10.3109\/13550289609146899"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Duncan J, Rudge P. Methylprednisolone therapy in tropical spastic paraparesis. J Neurol Neurosurg Psychiatry 53: 173-174, 1990.","DOI":"10.1136\/jnnp.53.2.173-a"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Croda M, de Oliveria A, Vergara M, et al. Corticosteroid therapy in TSP\/HAM patients: the results from a 10 years open cohort. J Neurol Sci 269: 133-137, 2008.","DOI":"10.1016\/j.jns.2008.01.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Jeffery K, Usuku K, Hall S, et al. HLA alleles determine HTLV-I proviral load and risk of HTLV-I associated myelopathy. Proc Natl Acad Sci USA 96: 3848-3853, 1999.","DOI":"10.1073\/pnas.96.7.3848"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T03:03:54Z","timestamp":1498187034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/1\/54_54.2950\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.2950","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}